fda tirzepatide shortage resolved date says that the GLP-1 is over Compounded Semaglutide & Tirzepatide 2025:

Torres K, Tuero I, Colarossi A

Retatrutide is currently still being evaluated in Phase 3 clinical trials, which means healthcare providers cannot yet prescribe it.[2] The drug is being developed by Eli Lilly and is being studied for potential treatment of obesity, type 2 diabetes, and fatty liver disease

That vacuum makes drawing medication difficult, causes air bubbles to form in the liquid, and can even pull the plunger back after you remove the syringe, wasting medication

Semaglutide may not be FDA-approved, but that doesnt mean its dangerous or ineffective

Topical Use Apply 23 drops on the face Use at night for better absorption Can be mixed with moisturiser Consistency matters more than quantity